Oragenics, Inc. Announces Conversion of Preferred Shares and Elimination of Liquidation Preference
SARASOTA, Fla., Dec. 16, 2024 (GLOBE NEWSWIRE) — Oragenics, Inc. (NYSE: OGEN), a biotechnology company advancing innovative treatments for brain-related […]